Found: 59
Select item for more details and to access through your institution.
Anti-PCSK9 antibodies for hypercholesterolaemia: Overview of clinical data and implications for primary care.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Use of the lactose-[13C]ureide breath test for diagnosis of small bowel bacterial overgrowth: comparison to the glucose hydrogen breath test.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Use of the lactose-[<sup>13</sup>C]ureide breath test for diagnosis of small bowel bacterial overgrowth: comparison to the glucose hydrogen breath test.
- Published in:
- Journal of Gastroenterology, 2009, v. 44, n. 9, p. 944, doi. 10.1007/s00535-009-0097-8
- By:
- Publication type:
- Article
Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial.
- Published in:
- 2006
- By:
- Publication type:
- journal article
PCSK9 Inhibition: Insights From Clinical Trials and Future Prospects.
- Published in:
- Frontiers in Physiology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphys.2020.595819
- By:
- Publication type:
- Article
Lipoprotein Metabolism, Dyslipidemia, and Lipid-Lowering Therapy in Women: A Comprehensive Review.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 7, p. 913, doi. 10.3390/ph17070913
- By:
- Publication type:
- Article
Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a).
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 4, p. 577, doi. 10.3390/ph16040577
- By:
- Publication type:
- Article
Lipoprotein (a) measurement: potential for personalized cardiovascular disease management in a patient with acute myocardial infarction.
- Published in:
- Archives of Medical Science, 2024, v. 20, n. 3, p. 1043, doi. 10.5114/aoms/188252
- By:
- Publication type:
- Article
The stable isotope ketoisocaproic acid breath test as a measure of hepatic decarboxylation capacity: a quantitative analysis in normal subjects after oral and intravenous administration.
- Published in:
- Liver International, 2009, v. 29, n. 9, p. 1356, doi. 10.1111/j.1478-3231.2009.02072.x
- By:
- Publication type:
- Article
Regulation of Mitogen-Activated Protein Kinase Cascades by Low Density Lipoprotein and Lysophosphatidic Acid.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2004, v. 14, n. 3, p. 167, doi. 10.1159/000078108
- By:
- Publication type:
- Article
Effects of authentic and VLDL hydrolysis-derived fatty acids on vascular smooth muscle cell growth.
- Published in:
- British Journal of Pharmacology, 2001, v. 132, n. 8, p. 1725, doi. 10.1038/sj.bjp.0704026
- By:
- Publication type:
- Article
Cholera toxin treatment of vascular smooth muscle cells decreases smooth muscle alpha-actin content and abolishes the platelet-derived growth factor-BB-stimulated DNA synthesis.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Early intracellular signalling pathway of ethanol in vascular smooth muscle cells.
- Published in:
- British Journal of Pharmacology, 1999, v. 128, n. 8, p. 1761, doi. 10.1038/sj.bjp.0702969
- By:
- Publication type:
- Article
Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effects of Lipid-Lowering Drugs on High-Density Lipoprotein Subclasses in Healthy Men—A Randomized Trial.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0091565
- By:
- Publication type:
- Article
Effects of Lipid-Lowering Drugs on Irisin in Human Subjects <i>In Vivo</i> and in Human Skeletal Muscle Cells <i>Ex Vivo</i>.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0072858
- By:
- Publication type:
- Article
Evidence from a Randomized Trial That Simvastatin, but Not Ezetimibe, Upregulates Circulating PCSK9 Levels.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0060095
- By:
- Publication type:
- Article
Randomized, Placebo-Controlled Trial of Mipomersen in Patients with Severe Hypercholesterolemia Receiving Maximally Tolerated Lipid-Lowering Therapy.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0049006
- By:
- Publication type:
- Article
Association between the Interleukin-6 Promoter Polymorphism 2174G/C and Serum Lipoprotein(a) Concentrations in Humans.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0024719
- By:
- Publication type:
- Article
Updates in Drug Treatment of Severe Hypertriglyceridemia.
- Published in:
- Current Atherosclerosis Reports, 2023, v. 25, n. 10, p. 701, doi. 10.1007/s11883-023-01140-z
- By:
- Publication type:
- Article
PCSK9 Monoclonal Antibodies: New Developments and Their Relevance in a Nucleic Acid–Based Therapy Era.
- Published in:
- Current Atherosclerosis Reports, 2022, v. 24, n. 10, p. 779, doi. 10.1007/s11883-022-01053-3
- By:
- Publication type:
- Article
Influence of ghrelin gene polymorphisms on hypertension and atherosclerotic disease.
- Published in:
- Hypertension Research, 2010, v. 33, n. 2, p. 155, doi. 10.1038/hr.2009.194
- By:
- Publication type:
- Article
New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk.
- Published in:
- 2014
- By:
- Publication type:
- Report
Significant Quality of Life Improvement Observed in a Patient With FCS Associated With a Marked Reduction in Triglycerides.
- Published in:
- Journal of the Endocrine Society, 2020, v. 4, n. 2, p. N.PAG, doi. 10.1210/jendso/bvz035
- By:
- Publication type:
- Article
Systematic review of published Phase 3 data on anti-PCSK9 monoclonal antibodies in patients with hypercholesterolaemia.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 6, p. 1412, doi. 10.1111/bcp.13066
- By:
- Publication type:
- Article
Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial.
- Published in:
- European Heart Journal, 2010, v. 31, n. 13, p. 1633, doi. 10.1093/eurheartj/ehq181
- By:
- Publication type:
- Article
Patterns and predictors of statin prescription in patients wit type 2 diabetes.
- Published in:
- Cardiovascular Diabetology, 2009, v. 8, p. 1, doi. 10.1186/1475-2840-8-25
- By:
- Publication type:
- Article
Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2001, v. 363, n. 2, p. 215, doi. 10.1007/s002100000352
- By:
- Publication type:
- Article
Short-term effects of high soy supplementation on sex hormones, bone markers, and lipid parameters in young female adults.
- Published in:
- European Journal of Nutrition, 2004, v. 43, n. 2, p. 100
- By:
- Publication type:
- Article
Effect of Policosanol on Lipid Levels Among Patients With Hypercholesterolemia or Combined Hyperlipidemia.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 295, n. 19, p. 2262, doi. 10.1001/jama.295.19.2262
- By:
- Publication type:
- Article
Linear accelerator radiosurgery for pituitary macroadenomas: A 7‐Year Follow‐Up Study.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 6, p. 1355
- By:
- Publication type:
- Article
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DAVINCI study.
- Published in:
- European Journal of Preventive Cardiology, 2021, v. 28, n. 11, p. 1279, doi. 10.1093/eurjpc/zwaa047
- By:
- Publication type:
- Article
LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial.
- Published in:
- European Journal of Preventive Cardiology, 2021, v. 28, n. 8, p. 805, doi. 10.1177/2047487320902750
- By:
- Publication type:
- Article
Effects of Vitamin D Supplementation on Renin and Aldosterone Concentrations in Patients with Advanced Heart Failure: The EVITA Trial.
- Published in:
- International Journal of Endocrinology, 2018, p. 1, doi. 10.1155/2018/5015417
- By:
- Publication type:
- Article
Daily Supplementation with 4000 IU Vitamin D3 for Three Years Does Not Modify Cardiovascular Risk Markers in Patients with Advanced Heart Failure: The Effect of Vitamin D on Mortality in Heart Failure Trial.
- Published in:
- Annals of Nutrition & Metabolism, 2019, v. 74, n. 1, p. 62, doi. 10.1159/000495662
- By:
- Publication type:
- Article
Influence of Simvastatin on apoB-100 Secretion in Non-Obese Subjects with Mild Hypercholesterolemia.
- Published in:
- Lipids, 2010, v. 45, n. 6, p. 491, doi. 10.1007/s11745-010-3420-5
- By:
- Publication type:
- Article
Does the coronary risk factor low density lipoprotein alter growth and signaling in vascular smooth muscle cells?
- Published in:
- FASEB Journal, 2002, v. 16, n. 12, p. 1477, doi. 10.1096/fj.02-0260rev
- By:
- Publication type:
- Article
Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women.
- Published in:
- Osteoporosis International, 2004, v. 15, n. 6, p. 459, doi. 10.1007/s00198-004-1598-1
- By:
- Publication type:
- Article
A 3 year post‐intervention follow‐up on mortality in advanced heart failure (EVITA vitamin D supplementation trial).
- Published in:
- ESC Heart Failure, 2020, v. 7, n. 6, p. 3754, doi. 10.1002/ehf2.12953
- By:
- Publication type:
- Article
Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti- PCSK9 Antibody in Statin-Intolerant Subjects 3 ( GAUSS-3) Trial.
- Published in:
- Clinical Cardiology, 2016, v. 39, n. 3, p. 137, doi. 10.1002/clc.22518
- By:
- Publication type:
- Article
Erratum to: LDL-Cholesterol: Standards of Treatment 2016: A German Perspective.
- Published in:
- American Journal of Cardiovascular Drugs, 2016, v. 16, n. 6, p. 475, doi. 10.1007/s40256-016-0187-y
- By:
- Publication type:
- Article
LDL-Cholesterol: Standards of Treatment 2016: A German Perspective.
- Published in:
- American Journal of Cardiovascular Drugs, 2016, v. 16, n. 5, p. 323, doi. 10.1007/s40256-016-0179-y
- By:
- Publication type:
- Article
Lipoprotein apheresis in isolated hyperlipoproteinemia(a): a validated treatment or an illusion of validity?
- Published in:
- European Journal of Clinical Investigation, 2013, v. 43, n. 1, p. 108, doi. 10.1111/eci.12014
- By:
- Publication type:
- Article
Vitamin D supplementation does not prevent the testosterone decline in males with advanced heart failure: the EVITA trial.
- Published in:
- European Journal of Nutrition, 2019, v. 58, n. 2, p. 673, doi. 10.1007/s00394-018-1666-5
- By:
- Publication type:
- Article
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 5, p. 941, doi. 10.1007/s10557-022-07343-x
- By:
- Publication type:
- Article
Lifibrol as a Model Compound for a Novel Lipid-Lowering Mechanism of Action.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2010, v. 15, n. 4, p. 364, doi. 10.1177/1074248410371100
- By:
- Publication type:
- Article
Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape--focus on hypertriglyceridaemia.
- Published in:
- Frontiers in Cardiovascular Medicine, 2024, p. 01, doi. 10.3389/fcvm.2024.1389106
- By:
- Publication type:
- Article
PCSK9 Antibodies for the Treatment of Hypercholesterolemia.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany.
- Published in:
- Clinical Research in Cardiology, 2024, v. 113, n. 6, p. 812, doi. 10.1007/s00392-023-02257-6
- By:
- Publication type:
- Article